News

This patent relates to methods and formulations for treating migraine, symptoms that often accompany migraine and acute pain such as photophobia, phonophobia, nausea and vomiting. The patent provides

Masitinib is an investigational orally administered tyrosine kinase inhibitor that targets mast cells, essential for immunity. In the study, 44 patients with inoperable, locally advanced or metastatic GIST

This certification will allow the company to accept clinical samples from most US states. Foundation Medicine achieved Massachusetts State licensing in October 2011, enabling the company to begin

The enhancements provide an outstanding and cost competitive services for filling Phase I/II drug products into vials or other containers, the company said. Florida Biologix provides either manual

The grants will help the company to further advance its MultiStem product programs and cell therapy platform. MultiStem cell therapy is a patented product that has shown the

The Nanobody development candidate is designed to interfere with the function of two distinct proteins that are thought to play a major role in human cancers. To date,

OctoPlus will provide both formulation development and clinical material manufacturing services to biotech and pharmaceutical companies across the globe. The undisclosed contract value is expected to make a

The transaction is expected to be immediately accretive. Probiotica currently markets a full line of OTC sports nutrition products and other food supplements, with a 30% share of

Anatabloc assists the body’s natural process for regulating inflammation using an alkaloid found in plants and vegetables, in combination with Vitamins A and D3, to help maintain healthy